LITTLE KNOWN FACTS ABOUT CONOLIDINE.

Inside of a latest review, we claimed the identification as well as the characterization of a completely new atypical opioid receptor with unique adverse regulatory Houses to opioid peptides.1 Our effects confirmed that ACKR3/CXCR7, hitherto referred to as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is likewise a broad-spectrum